SCHEMBL10700342

SCHEMBL10700342

C[C](C)CNS(=O)(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 3/20 0.56
MMP12 P39900 2/20 0.56
GAA P10253 1/20 0.56
ALDH1A1 P00352 3/20 0.55
KEAP1 Q14145 1/20 0.55
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.55
PKM P14618 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MAPK1 P28482 1/20 0.54
CYP2C19 P33261 1/20 0.53
MMP2 P08253 2/20 0.52
MMP9 P14780 2/20 0.52
MMP8 P22894 2/20 0.52
MMP13 P45452 2/20 0.52
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
BCAT1 P54687 1/20 0.52
MMP3 P08254 1/20 0.51
MMP7 P09237 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10788040 0.86 MMP1 (0.59) MMP1MMP12GAAALDH1A1KEAP1
SCHEMBL2760714 0.85 MMP1 (0.61) MMP1MMP12GAAALDH1A1KEAP1
SCHEMBL7784368 0.85 CA1 (0.70) MMP1MMP12GAAALDH1A1KEAP1
SCHEMBL359770 0.82 MMP1 (0.79) MMP1MMP12GAAALDH1A1MMP2
SCHEMBL11568507 0.80 MMP1 (0.56) MMP1MMP12GAAALDH1A1KEAP1
SCHEMBL13758640 0.79 HSD11B1 (0.56) MMP1MMP12GAAALDH1A1KEAP1
SCHEMBL3239227 0.79 ALDH1A1 (0.71) MMP1MMP12GAAALDH1A1KEAP1
SCHEMBL6362669 0.79 MMP1 (0.47) MMP1MMP12GAAALDH1A1KEAP1
SCHEMBL5450999 0.79 ALDH1A1 (0.63) MMP1MMP12GAAALDH1A1KEAP1
SCHEMBL2969958 0.78 MMP1 (0.59) MMP1MMP12GAAALDH1A1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897970-B1 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2016-07-13 EP claimed
US-20150210729-A1 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2015-07-30 US claimed
EP-2897970-A1 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2015-07-29 EP claimed
WO-2014044645-A1 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2014-03-27 WO claimed
EP-2897970-B1 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2016-07-13 EP disclosed
US-20150210729-A1 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2015-07-30 US disclosed
EP-2897970-A1 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2015-07-29 EP disclosed
WO-2014044645-A1 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2014-03-27 WO disclosed
EP-0284099-A2 Silver halide color photographic materials FUJI PHOTO FILM CO., LTD. (JP) 1988-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210729-A1 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF PCSK9, CYP51A1, ABCB11 MMP1 2904/4885MMP12 636/4885GAA 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.